<- Go Home

Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Market Cap

MXN 23.2B

Volume

3.7M

Cash and Equivalents

MXN 2.3B

EBITDA

MXN 4.3B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

MXN 11.9B

Profit Margin

64.12%

52 Week High

MXN 29.18

52 Week Low

MXN 13.90

Dividend

3.38%

Price / Book Value

2.00

Price / Earnings

10.87

Price / Tangible Book Value

4.33

Enterprise Value

MXN 27.4B

Enterprise Value / EBITDA

6.39

Operating Income

MXN 4.0B

Return on Equity

20.33%

Return on Assets

11.11

Cash and Short Term Investments

MXN 2.3B

Debt

MXN 6.5B

Equity

MXN 11.6B

Revenue

MXN 18.6B

Unlevered FCF

MXN 1.1B

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches